EpiPen Makers Agree To $4.5M Deal With Maryland Over Its Pricing, Marketing

EpiPen Makers Agree To $4.5M Deal With Maryland Over Its Pricing, Marketing The settlement comes after the makers were accused of using a monopoly to increase prices, requiring injectors to be purchased in a two-pack, and restricting generic versions of the EpiPen. https://kffhealthnews.org/morning-breakout/states-115/